Skip to content
Recall Observatory FDA recall evidence

Drug product

Dabigatran Etexilate Capsules, 75 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-474-60.

D-0533-2023

March 14, 2023

Class II

Product summary

Firm
Ascend Laboratories, LLC
Event
Event 91880
Status
Ongoing
Classification
Class II
Quantity
13,560 bottles
Official record key
drug-enforcement:D-0533-2023

Official wording

Reason: CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.

Code information: Lot #s: 22142462, 22142463, 22142464, Exp 5/2024; 22143000, 22143001, 22143002, Exp 6/2024.

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations